The report presents detailed analysis of the STD market in the France, Germany, Italy, Spain, and UK. Current scientific views on epidemiology and etiology are presented for:
- AIDS/HIV
- Chancroid
- Chlamydia
- Gonorrhea
- Granuloma Inguinale
- Herpes I/II
- Lymphogranuloma
- Mycoplasma
- Papillomavirus
- Syphilis
- Trichomonas Vaginalis
- Hospitals
- Commercial/Private Labs
- Public Health Labs
- Reviews features and operating characteristics of major analyzers used for STD testing;
- Profiles key suppliers and potential market entrants developing innovative technologies and products; and analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the five major European countries.In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako

